Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.


The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

My NCBI Filters
Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
1959 1
1962 3
1963 1
1964 1
1965 1
1967 1
1968 1
1969 3
1971 1
1972 1
1974 4
1975 9
1976 3
1977 4
1978 2
1979 5
1980 2
1981 1
1982 6
1983 4
1984 8
1985 11
1986 9
1987 18
1988 23
1989 32
1990 26
1991 35
1992 18
1993 37
1994 33
1995 47
1996 37
1997 52
1998 48
1999 73
2000 56
2001 84
2002 102
2003 127
2004 152
2005 183
2006 188
2007 223
2008 268
2009 348
2010 388
2011 434
2012 513
2013 630
2014 645
2015 707
2016 759
2017 771
2018 832
2019 911
2020 1072
2021 1220
2022 1234
2023 14
Text availability
Article attribute
Article type
Publication date

Search Results

11,110 results
Results by year
Filters applied: . Clear all
Page 1
Authors' response.
Kang Y, Lee S, Gong Y, Kim SH, Moon CH. Kang Y, et al. Am J Orthod Dentofacial Orthop. 2022 Oct;162(4):439-440. doi: 10.1016/j.ajodo.2022.07.009. Am J Orthod Dentofacial Orthop. 2022. PMID: 36182203 No abstract available.
The m6A reader IGF2BP2 regulates glutamine metabolism and represents a therapeutic target in acute myeloid leukemia.
Weng H, Huang F, Yu Z, Chen Z, Prince E, Kang Y, Zhou K, Li W, Hu J, Fu C, Aziz T, Li H, Li J, Yang Y, Han L, Zhang S, Ma Y, Sun M, Wu H, Zhang Z, Wunderlich M, Robinson S, Braas D, Hoeve JT, Zhang B, Marcucci G, Mulloy JC, Zhou K, Tao HF, Deng X, Horne D, Wei M, Huang H, Chen J. Weng H, et al. Among authors: kang y. Cancer Cell. 2022 Oct 26:S1535-6108(22)00495-0. doi: 10.1016/j.ccell.2022.10.004. Online ahead of print. Cancer Cell. 2022. PMID: 36306790
Faecalibacterium prausnitzii Attenuates CKD via Butyrate-Renal GPR43 Axis.
Li HB, Xu ML, Xu XD, Tang YY, Jiang HL, Li L, Xia WJ, Cui N, Bai J, Dai ZM, Han B, Li Y, Peng B, Dong YY, Aryal S, Manandhar I, Eladawi MA, Shukla R, Kang YM, Joe B, Yang T. Li HB, et al. Among authors: kang ym. Circ Res. 2022 Oct 14;131(9):e120-e134. doi: 10.1161/CIRCRESAHA.122.320184. Epub 2022 Sep 27. Circ Res. 2022. PMID: 36164984 Free article.
Molecular mechanism of the wake-promoting agent TAK-925.
Yin J, Kang Y, McGrath AP, Chapman K, Sjodt M, Kimura E, Okabe A, Koike T, Miyanohana Y, Shimizu Y, Rallabandi R, Lian P, Bai X, Flinspach M, De Brabander JK, Rosenbaum DM. Yin J, et al. Among authors: kang y. Nat Commun. 2022 May 25;13(1):2902. doi: 10.1038/s41467-022-30601-3. Nat Commun. 2022. PMID: 35614071 Free PMC article.
Silver based photocatalysts in emerging applications.
Zhang Y, Liu J, Kang YS, Zhang XL. Zhang Y, et al. Among authors: kang ys. Nanoscale. 2022 Aug 25;14(33):11909-11922. doi: 10.1039/d2nr02665a. Nanoscale. 2022. PMID: 35959864 Review.
Emerging Biomaterials Imaging Antitumor Immune Response.
Ma X, Zhang MJ, Wang J, Zhang T, Xue P, Kang Y, Sun ZJ, Xu Z. Ma X, et al. Among authors: kang y. Adv Mater. 2022 Oct;34(42):e2204034. doi: 10.1002/adma.202204034. Epub 2022 Sep 18. Adv Mater. 2022. PMID: 35728795 Review.
Regulation and roles of FOXK2 in cancer.
Kang Y, Zhang K, Sun L, Zhang Y. Kang Y, et al. Front Oncol. 2022 Sep 12;12:967625. doi: 10.3389/fonc.2022.967625. eCollection 2022. Front Oncol. 2022. PMID: 36172141 Free PMC article. Review.
Water Quality Prediction Based on SSA-MIC-SMBO-ESN.
Kang Y, Song J, Lin Z, Huang L, Zhai X, Feng H. Kang Y, et al. Comput Intell Neurosci. 2022 Aug 3;2022:1264385. doi: 10.1155/2022/1264385. eCollection 2022. Comput Intell Neurosci. 2022. PMID: 35965755 Free PMC article.
Zebrafish: an important model for understanding scoliosis.
Xie H, Li M, Kang Y, Zhang J, Zhao C. Xie H, et al. Among authors: kang y. Cell Mol Life Sci. 2022 Sep 4;79(9):506. doi: 10.1007/s00018-022-04534-5. Cell Mol Life Sci. 2022. PMID: 36059018 Free PMC article. Review.
Safety and immunogenicity of a hybrid-type vaccine booster in BBIBP-CorV recipients in a randomized phase 2 trial.
Kaabi NA, Yang YK, Du LF, Xu K, Shao S, Liang Y, Kang Y, Su JG, Zhang J, Yang T, Hussein S, ElDein MS, Yang SS, Lei W, Gao XJ, Jiang Z, Cong X, Tan Y, Wang H, Li M, Mekki HM, Zaher W, Mahmoud S, Zhang X, Qu C, Liu DY, Zhang J, Yang M, Eltantawy I, Hou JW, Lei ZH, Xiao P, Wang ZN, Yin JL, Mao XY, Zhang J, Qu L, Zhang YT, Yang XM, Wu G, Li QM. Kaabi NA, et al. Among authors: kang y. Nat Commun. 2022 Jun 27;13(1):3654. doi: 10.1038/s41467-022-31379-0. Nat Commun. 2022. PMID: 35760812 Free PMC article. Clinical Trial.
11,110 results
You have reached the last available page of results. Please see the User Guide for more information.